rare disease

(redirected from Orphan diseases)

rare disease

See Orphan disease.
References in periodicals archive ?
is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary disorders.
("Rezolute") (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of transformative therapies targeting metabolic and orphan diseases, announced today that Handok, Inc.
Aevi's initial focus of study with ASP7486 will be for congenital Lymphatic Malformations, which includes a number of rare and orphan diseases. The mTORC1/2 pathway is believed to be involved in greater than 80% of patients with congenital Lymphatic Malformations.
565-2019 / Minsa, the Ministry of Health established the Sectoral Commission that will be responsible for updating the List of Rare or Orphan Diseases for the benefit of people suffering from rare diseases.
Summary: Orphan diseases can be defined as the medical conditions which impacts a small group of the population and are mostly genetic in nature.
[UKPRwire, Thu Jun 27 2019] Orphan diseases can be defined as the medical conditions which impacts a small group of the population and are mostly genetic in nature.
With the resources obtained in this new round of financing, SOM Biotech wants to give a strong boost to its expansion, strengthen its licensing and co-development activities and build up the international presence necessary to become a world leader in the field of repurposing drugs for orphan diseases mainly in the Central Nervous System space.
Request Free sample report @ https://www.mrrse.com/sample/3587 Orphan diseases can be defined as the medical conditions which impacts a small group of the population and are mostly genetic in nature.
"Increasing the Orphan Disease Tax Credit is key to development of treatments for orphan diseases because it allows the researchers to maintain the capital necessary to complete their research and bring a treatment to market.
CANbridge Pharmaceuticals is a China-based biopharmaceutical company accelerating development and commercialization of specialty healthcare products for orphan diseases and targeted cancers, focusing on products that are unavailable or address medical needs that are underserved in the region.
Orphan diseases are diseases that affect less than 200,000
Summary: New Delhi [India], Mar 08 (ANI): Rare diseases, which are often referred to as orphan diseases, are estimated to have impacted 72-96 million people in India.